← Back to all trials
Not Yet Recruiting
NCT07264920
Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain
Conditions: Neuropathic Pain, Chronic Pain
Sex: All
Ages: 5 Years – 26 Years
Healthy volunteers: No
Phase: NA
Enrollment: 70
Sponsor: Johns Hopkins University
Location: Johns Hopkins Children's Center Baltimore Maryland
Summary
This is a study evaluating the Scrambler Therapy device as a non-invasive treatment for neuropathic pain in pediatric oncology patients with metastatic bone disease. The primary goal is to assess changes in pain intensity and medication use, aiming to improve quality of life and reduce reliance on systemic pain medications.
Eligibility Criteria
Inclusion Criteria:
* Able to verbalize pain scores
* Oncology patients with acute and/or chronic pain
Exclusion Criteria:
* Patients with Implantable Devices
* Epilepsy
* Pregnancy
* A history of myocardial infarction or ischemic heart disease within the past six months
* History of severe heart arrhythmia or equivalent heart disease
* Open Wounds or Infections at site of electrode placement
* A history of intolerance to transcutaneous electronic nerve stimulation
Source: ClinicalTrials.gov (NCT07264920). StuddyBuddy aggregates publicly available trial information.
